Disclaimer
Access to the information and documents on this part of the website is restricted for regulatory reasons. You are requested to review the following information and make the following confirmation each time you seek to access this restricted information.
Your confirmation must be true and accurate.
IMPORTANT INFORMATION: Due to applicable legal restrictions, the information contained in this section of the website is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part, in or into the United States of America, Australia, Canada, New Zealand, Hong Kong, Japan, Switzerland, Singapore, United Kingdom, South Africa, South Korea, Russia, Belarus or any other jurisdiction in which such release, publication or distribution would be unlawful. We apologize for any inconvenience this may cause. Please return to the homepage.
IMPORTANT INFORMATION: Due to applicable legal restrictions, the information contained in this section of the website is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part, in or into the United States of America, Australia, Canada, New Zealand, Hong Kong, Japan, Switzerland, Singapore, United Kingdom, South Africa, South Korea, Russia, Belarus or any other jurisdiction in which such release, publication or distribution would be unlawful. We apologize for any inconvenience this may cause. Please return to the homepage.
Important information
Access to the information and documents on this portion of the website is restricted for regulatory reasons. You are requested to review the following information and make the following confirmation each time you seek to access this restricted information. Your confirmation must be true and accurate.
The information contained in this section of the website of Precise Biometrics AB (publ) (the “Company”) is (a) only intended for, and may only be accessed by, or distributed or disseminated, directly or indirectly, in whole or in part, to persons resident and physically present outside the United States of America (including its territories and possessions, any state of the United States and the District of Columbia, the “United States”), Australia, Canada, New Zealand, Hong Kong, Japan, Switzerland, Singapore, United Kingdom, South Africa, South Korea, Russia, Belarus and resident and physically present in a jurisdiction where to do so will not constitute a violation of the local securities laws or regulations of such jurisdiction, and (b) does not constitute an offer to sell or the solicitation of an offer to buy or acquire any securities of the Company in the United States, Australia, Canada, New Zealand, Hong Kong, Japan, Switzerland, Singapore, United Kingdom, South Africa, South Korea, Russia, Belarus or any other jurisdiction where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction.
The securities of the Company referred to in this section of the website (the “Securities”) have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”) or with any securities regulatory authority of any state of the United States for offer or sale as part of their distribution and may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. The Securities have not been and will not be registered under the applicable securities laws of Australia, Canada, New Zealand, Hong Kong, Japan, Switzerland, Singapore, United Kingdom, South Africa, South Korea, Russia, Belarus or any other jurisdiction in which it would be unlawful or would require registration or other measures, and therefore may not be offered or sold to or for the account or benefit of any person having a registered address in, or located or resident in, Australia, Canada, New Zealand, Hong Kong, Japan, Switzerland, Singapore, United Kingdom, South Africa, South Korea, Russia, Belarus or any other jurisdiction in which it would be unlawful or would require registration or other measures.
In the United Kingdom, the information contained in this section of the Company’s website is only being distributed to and is only directed at “qualified investors” within the meaning of Article 2(e) of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC (together with any related implementing and delegated regulations, the “Prospectus Regulation”), as it forms part of domestic law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 who are (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”); or (ii) high net worth companies, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons in (i) and (ii) above together being referred to as “relevant persons”). The Securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on the information contained in this section of the Company’s website.
In any EEA Member State, other than Sweden, where the Prospectus Regulation is applicable, the information contained in this section of the Company’s website are only addressed to and are only directed at qualified investors within the meaning of the Prospectus Regulation.
Access to the information contained on this portion of the website may be illegal in certain jurisdictions, and only certain categories of persons may be authorized to access such information and documents. All persons who wish to have access to the documents contained in this section of the Company’s website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this section of the website, or require registration or approval for any acquisition of securities by them. No such registration or approval has been or will be obtained. The Company assumes no responsibility if there is a violation of applicable law and regulations by any person.
If you are not permitted to view materials on this webpage or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.
I therefore certify that:
- I am resident and physically present in a country outside the United States, Australia, Canada, New Zealand, Hong Kong, Japan, Switzerland, Singapore, United Kingdom, South Africa, South Korea, Russia and Belarus;
- I am authorized to access the information and documents contained on this portion of the website without being subject to any legal restriction and without any further action required by the Company;
- I will not transmit or otherwise send any information contained in this website to publications with a general circulation in the United States; and
- I have read, understand and agree to comply with all of the restrictions set forth above.
DISCLAIMER – IMPORTANT: Due to applicable legal restrictions, the information contained in this section of the website is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part, in or into the United States of America, Australia, Canada, New Zealand, Hong Kong, Japan, Switzerland, Singapore, United Kingdom, South Africa, South Korea, Russia, Belarus or any other jurisdiction in which such release, publication or distribution would be unlawful.
We apologise for any inconvenience this may cause. Click here to return to the homepage.
Precise Biometrics publishes information document regarding rights issue
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, WITHIN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, THE UNITED KINGDOM, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE ADDITIONAL REGISTRATION OR OTHER MEASURES. SEE SECTION “IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE.
Information document
The Company has prepared an information document regarding the admission to trading of the shares issued in the Rights Issue, in accordance with Article 1.5 ba of Regulation (EU) 2017/1129 of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC (the “Prospectus Regulation” and the “Information Document”, respectively). The Information Document has been prepared in accordance with the requirements of Annex IX to the Prospectus Regulation.
Today, Precise Biometrics announces that the Information Document has been registered with the Swedish Financial Supervisory Authority (Sw. Finansinspektionen) and is available on the Company’s website www.precisebiometrics.com and on www.dnbcarnegie.se.
Preliminary timetable for the Rights Issue
The timetable below is preliminary and subject to change.
| Last day of trading in the Company’s shares, including the right to receive subscription rights | 23 July 2026 |
| First day of trading in the Company’s shares excluding the right to receive subscription rights | 24 July 2026 |
| Record date for participation in the Rights Issue | 27 July 2026 |
| Publication of the Information Document | 28 July 2026 |
| Trading in subscription rights | 29 July – 7 August 2026 |
| Subscription period | 29 July – 12 August 2026 |
| Trading in paid subscribed shares (BTA) | 29 July – 18 August 2026 |
| Announcement of the final outcome of the Rights Issue | 13 August 2026 |
Advisors
DNB Carnegie Investment Bank AB is acting as financial advisor and Vinge is acting as legal advisor to the Company in connection with the Rights Issue.
Important information
For the purposes of this disclaimer, “this press release” means this document, its contents or any part of them, any oral presentation, any question-and-answer session and any written or oral materials discussed or distributed therein.
This press release does not constitute a prospectus or an offering document. Nor does this press release constitute an offer to sell, or a solicitation or invitation to make an offer to buy, acquire or subscribe for, securities, or an inducement to make any investment, and no sale of securities will take place in jurisdictions where such an offer, invitation or sale would be unlawful without registration or qualification under the securities laws of such jurisdiction.
This press release may not be made public, published or distributed, either directly or indirectly, in or into Australia, Belarus, Canada, Hong Kong, Japan, New Zealand, Russia, Singapore, South Africa, South Korea, Switzerland, the United Kingdom, the United States, or any other jurisdiction where such action, in whole or in part, would be subject to legal restrictions or would require additional information documents, registration, or other measures beyond those required by Swedish law. The information in this press release may not be forwarded or reproduced in a manner that is inconsistent with such restrictions or would entail such requirements. Any violation of these instructions may constitute a breach of applicable securities laws.
This press release does not constitute an offer or invitation to acquire or subscribe for securities in the United States. The securities referred to herein may not be sold in the United States without registration, or without the application of an exemption from registration, under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and may not be offered or sold in the United States unless they are registered, covered by an exemption from, or in a transaction not subject to the registration requirements of the Securities Act. There is no intention to register any securities mentioned herein in the United States or to make a public offering of such securities in the United States.
In the United Kingdom, this document and other materials relating to the securities mentioned herein are distributed and directed solely to, and any investment or investment activity related to this document is available only to and may be undertaken only by, “qualified investors” who are (i) persons who have professional experience in investment-related activities and who fall within the definition of “professional investors” in Article 19(5) of the UK Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”); or (ii) high-net-worth individuals as defined in Article 49(2)(a)-(d) of the Order (all such persons are collectively referred to as “relevant persons”). An investment or investment-related activity to which this announcement relates is available in the United Kingdom solely to relevant persons and will be conducted only with relevant persons. Persons who are not relevant persons should not take any action based on this press release, nor should they act upon or rely on it.
This press release contains forward-looking statements. By their nature, forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors because they relate to events and depend on circumstances that will occur in the future whether or not outside the control of Precise Biometrics. Such factors may cause actual results, performance or developments to differ materially from those expressed or implied by such forward-looking statements. Undue reliance should not be placed on forward-looking statements. The forward-looking statements speak only as at the date of this press release and Precise Biometrics does not undertake any obligation to update the forward-looking statements except to the extent required by applicable law.